BioCatalyst

HEC585 dose A, HEC585 dose B — catalyst calendar

1 verified catalyst event(s) referencing HEC585 dose A, HEC585 dose B, each linked to its official source. Verified as of 2026-09-20.

Upcoming

DateEventCompanyDrugOfficial source & verification
2026-12 (month)
in 2mo
ESTIMATED
 READOUT
A Study to Explore the Therapeutic Effect of HEC585 on Delaying Forced Vital Cap
Phase 2 · Progressive Fibrosing Interstitial Lung Disease (PF-ILD) / Progressive Pulmonary Fibrosis (PPF)
 Sunshine Lake Pharma Co., Ltd. HEC585 dose A, HEC585 dose B ClinicalTrials.gov ↗
✓ Source-checked 2026-09-20
Sponsor-projected date — can change
Disclaimer. Bio Catalyst Calendar is a public-events data calendar. Every date is sourced and linked to an official record (ClinicalTrials.gov, FDA / Federal Register, openFDA). It is scheduling and reference data only — NOT investment advice, a recommendation, or a buy/sell signal. Dates set by sponsors and the FDA can change; always confirm against the linked official source.